Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Dreimer200on Aug 11, 2018 12:12pm
104 Views
Post# 28444707

RE:RE:RE:RE:RE:RE:PDT mediated immune therapy of brain tumors

RE:RE:RE:RE:RE:RE:PDT mediated immune therapy of brain tumors
“Minor copy errors happen all the time.”
 
Sigh. You are forcing me to become tiresome – but I am up to the challenge!
 
“demonstrated by the ability of a locally induced immune response to aect distant non-treated areas.”  
 
“using both ourecent guided resction”
 
“Additionally, none of these clinical trials have included an evaluation of the eects of PDT”
 
“There have been few experimental studies exploring the eects of direct PDT of brain tumors.”
 
“To overcome the difculties of ...”
 
“the immune stimulatory eects of ex vivo”
 
“PDT treated tumor cells were more eective as preventative ...”
 
It seems obvious that part of the difficulty arises from a malfunctioning “f” key on someone’s computer. My own 9-year-old laptop has a similar problem with the “l” key. On the other hand – if I planned to publish a scientific paper – I would think it prudent to proofread before publishing.

?
 
Bullboard Posts